Sector Chart Vertex Pharmaceuticals Incorporated

VRTX

US92532F1003

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Sector Other Pharmaceuticals

	Capi.	Sales Growth	Profitability	Finances	EV / Sales	P/E
VERTEX PHARMACEUTICALS INCORPORATED	126B
ELI LILLY AND COMPANY	1,063B
JOHNSON & JOHNSON	611B
ABBVIE INC.	444B
ROCHE HOLDING AG	324B
ASTRAZENECA PLC	285B

Real-time Estimate Cboe BZX Other stock markets 22:25:22 02/07/2026 HKT			5-day change	1st Jan Change
518.11 ^USD	+4.04%		+7.46%	+13.82%

04:10pm	Vertex Pharmaceuticals Incorporated Receives Us Fda Approval for Expanded Use of Casgevy for Treatment of People Ages 2 Years and Older with Sickle Cell Disease or Transfusion-Dependent Beta Thalassemia	CI
03:55pm	Vertex Pharmaceuticals Says FDA Approves Expanded Use of Casgevy in Younger Children With Blood Disorders	MT

Sector Chart Vertex Pharmaceuticals Incorporated

Stocks

VRTX

US92532F1003

Pharmaceuticals

Sector Other Pharmaceuticals